Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BFX
|
|||
| Drug Name |
PB-1120
|
|||
| Synonyms |
Insulin-ELP
Click to Show/Hide
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Helodermin-preferring VIP receptor (VIPR2) | Target Info | Modulator | [1] |
| KEGG Pathway | cAMP signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| Reactome | G alpha (s) signalling events | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| GPCRs, Class B Secretin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Company report (PhaseBio) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.